(Reuters) - U.S. health regulators granted orphan drug status to Threshold Pharmaceutical Inc's experimental cancer drug, TH-302. Earlier this month, the drug was given an orphan drug status by the European health regulators. (Reporting by Kav...
Source: http://health.yahoo.net/news/s/nm/threshold-cancer-drug-gets-orphan-status-in-u-s
Medal of Honor Lion King The Vampire Diaries Grand Slam
No comments:
Post a Comment
Note: only a member of this blog may post a comment.